Development of nerve growth factor (NGF) inhibition as a strategy for treatment of pain

J Peripher Nerv Syst. 2014 Oct:19 Suppl 2:S12-3. doi: 10.1111/jns.12080_3.
No abstract available

Publication types

  • Review

MeSH terms

  • Animals
  • Antibodies, Monoclonal, Humanized / therapeutic use*
  • Diabetic Neuropathies / drug therapy*
  • Follow-Up Studies
  • Humans
  • Nerve Growth Factor / adverse effects
  • Nerve Growth Factor / immunology*
  • Randomized Controlled Trials as Topic

Substances

  • Antibodies, Monoclonal, Humanized
  • Nerve Growth Factor
  • tanezumab